Form 4: Astrana Health Executive John Vong Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
John Vong, Chief Accounting Officer of Astrana Health, Inc., disposed of 636 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock.
Summary
- On May 12, 2024, John Vong, the Chief Accounting Officer of Astrana Health, Inc., disposed of 636 shares of common stock.
- The transaction was executed to cover tax withholding obligations associated with the vesting of restricted stock.
- The shares were disposed of at a price of $38.89 per share.
- Following the transaction, Vong beneficially owns 18,617 shares of Astrana Health, Inc.
- This total includes 14,927 shares of restricted stock that will vest over several future dates, contingent upon continuous employment and, in some cases, achievement of performance goals.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing detailing an executive's share disposal for tax purposes. It doesn't inherently convey positive or negative sentiment, but the continued vesting of restricted stock suggests ongoing commitment.
Future Outlook
The document outlines the vesting schedule for restricted stock held by John Vong, contingent on continued employment and achievement of performance goals. This indicates a long-term incentive structure tied to the company's performance.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. The vesting schedules and performance-based vesting align with common practices in incentivizing executives.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units (RSUs) that vest over time, similar to the structure described in the filing.
- Performance-based vesting is also a common practice to align executive incentives with company goals.
- Companies like UnitedHealth Group and CVS Health also utilize similar equity-based compensation plans for their executives.
Stakeholder Impact
- The transaction has a minimal direct impact on shareholders, as it is a routine disposal of shares by an executive to cover tax obligations.
- The vesting schedule of restricted stock incentivizes the executive to remain with the company and achieve performance goals, which could indirectly benefit shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/12/2024 | Date of transaction: John Vong disposed of 636 shares of Astrana Health common stock. |
| 05/14/2024 | Date of signature on the Form 4 filing. |
| 07/11/2024 | First vesting date for 942 shares of restricted stock. |
| 11/30/2024 | First vesting date for 570 shares of restricted stock. |
| 11/12/2024 | First vesting date for multiple tranches of restricted stock (1,361 shares, 1,360 shares, 5,326 shares). |
| 07/11/2025 | Second vesting date for 942 shares of restricted stock. |
| 07/11/2026 | Final vesting date for 945 shares of restricted stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.